Skip to main content
Log in

Markers of slow-healing peptic ulcer in the elderly

A study on 1,052 ranitidine-treated patients

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Little is known about ulcer outcome in the elderly. The aims of the present paper were to establish whether risk factors of slow-healing peptic ulcer can be demonstrated in the elderly and whether clinical differences exist between ulcer patients whose age of onset of the disease was before or after 65 years old. The short-term, open study, involving 1052 elderly patients (over 65 years) in 37 gastroenterology centers throughout Italy aimed to compare two schedules of ranitidine treatment: 150 mg twice daily versus 300 mg at bedtime. As nonsignificant differences were found between these two schedules, the sample was considered as a whole. It included 319 gastric ulcer (GU) patients, 699 duodenal ulcer (DU) patients, and 34 concomitant GU and DU cases. Ninety-three patients dropped out of the trial; 79/294 GU, 138/635 DU, and 10/30 GU+DU were found still unhealed after four weeks and 20 GU, 15 DU, and 1 GU+DU remained so after eight weeks. Statistical analysis was performed using likelihood-ratio and Pearson's chi-squared tests and Cox's models. Univariate analysis showed that the indicators of slow-healing GU were ulcer size (P=0.002) and persisting ulcer symptoms (P=0.0001); indicators of slow-healing DU were ulcer size (P=0.0001), persisting ulcer symptoms (P=0.0001), alcohol (P=0.0003), and NSAID (P=0.0088) consumption. DU patients taking antiplatelet drugs have significantly better results after four weeks and worse results after eight weeks (P=0.0352). Cox's models revealed that the persistence of ulcer symptoms is the most important factor predicting unhealing ulcers (GU,P=0.0008; DU,P=0.0002), while ulcer size is only important for DU (P=0.0215). Patients with ulcer disease onset before 65 years of age were more frequently males; DU subjects were more frequently smokers, with a family history of ulcer and no NSAID consumption. In conclusion, persistence of ulcer symptoms and ulcer size are indicators of slow-healing ulcer in the elderly; in the case of DU, NSAID and alcohol consumption may be additional factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Permut RP, Cello JP: Duodenal ulcer disease in the hospitalized elderly patients. Dig Dis Sci 27:1–5, 1982

    Google Scholar 

  2. Lockhart SP, Schofield PM, Gribble RJ, Baron JH: Upper gastrointestinal endoscopy in the elderly. Br Med J 290:283–287, 1985

    Google Scholar 

  3. Battaglia G, Di Mario F, Vio A, Gottardello L, Pasqualetti P, Grassi SA, Naccarato R, Pilotto A, Azzini CF: H2-blockers in the treatment of ulcer disease in the elderly. Adv Ther 7(2):78–85, 1990

    Google Scholar 

  4. Dickinson RJ, Royston CMS, Sutton DR: A comparison of famotidine and ranitidine in an elderly population: A multicentre study. Postgrad Med J 62(suppl 2):63–65, 1986

    Google Scholar 

  5. Battaglia G, Di Mario F, Vigneri S, Mazzacca M, Naccarato R: Peptic ulcer in the elderly. A double-blind, multicentre, short-term study comparing nizatidine 300 mg and ranitidine 300 mg. J Clin Gastroenterol (submitted)

  6. Ehsanullah RSB, Mills JG, Wood JR: Use of ranitidine to treat duodenal ulceration in the elderly. Gastroenterology 100(5, suppl 2):A58, 1991

    Google Scholar 

  7. Di Mario F, Vio A, Grassi SA, Pilotto A, Vigneri S, Battaglia G, Pasqualetti P, Naccarato R: La malattia ulcerosa nell'anziano: Studio a breve termine, multicentrico, randomizzato con ranitidina 150 mg/bid versus ranitidina 300 mg/nocte. Basi Raz Ter 21:109–118, 1991

    Google Scholar 

  8. Massarrat S, Eisenmann A: Factors affecting the healing rate of duodenal and pyloric ulcers with low dose antacid treatment. Gut 22:97–102, 1981

    Google Scholar 

  9. Sonnenberg A, Muller-Lissner SA, Vogel E, Schmid P, Gonvers JJ, Peter P, Strohmeyer G, Blum AL: Predictors of duodenal ulcer healing and relapse. Gastroenterology 81:1061–1067, 1981

    Google Scholar 

  10. Korman MG, Hansky J, Eaves SR, Schmidt GT: Influence of cigarette smoking on healing and relapse in duodenal ulcer. Gastroenterology 85:871–874, 1983

    Google Scholar 

  11. Lam SK, Koo J: Accurate prediction of duodenal ulcer healing rate by discriminant analysis. Gastroenterology 85:403–412, 1983

    Google Scholar 

  12. Granelli P, Angelini GP, Celli L: Unsuccessful cimetidine treatment of peptic ulcer: Analysis of the factors involved. Clin Ther 6:294–301, 1984

    Google Scholar 

  13. Van Deventer GM, Fullmantl H, Schneidman D, Walsh J: Predictors of delayed ulcer healing in an efficacy trial of sucralfate and cimetidine alone and in combination for treatment of active duodenal ulcer. Gastroenterology 88:1623–1628, 1985

    Google Scholar 

  14. Gugler R, Jensen JC, Rohner HG, Reimmitz P, Somogyi A: Factors predicting the therapeutic outcome of duodenal ulcer treatment with H2-receptor antagonists. Klin Wochenschr 63;1152–1159, 1985

    Google Scholar 

  15. O'Rourke IC: Elective surgery for peptic ulcer: A five-year review. Med J Austr 143:13–15, 1985

    Google Scholar 

  16. Lam SK, Lai CL, Ng M, Fok KH, Hui WM: Duodenal ulcer healing by separate reduction of post-prandial and nocturnal acid secretion have different pathophysiology. Gut 26:1038–1044, 1985

    Google Scholar 

  17. Leung FW, Reedy TJ, Van Deventer GM, Guth PH: Reduction in index of oxygen saturation at margin of active duodenal ulcers may lead to slow healing. Dig Dis Sci 34;417–423, 1989

    Google Scholar 

  18. Blum AL, Arnold R, Classen M, Goebell H, Fischer M, Witzel L, the RUDER Study Group: RUDER—prospective study of the risk factors for duodenal ulcer healing in 2109 patients. Gastroenterology 96:A47, 1989

    Google Scholar 

  19. Hetzel DJ, Hanskey PJ, Shearman DJC, Korman MG, Hecker R, Taggart GJ, Jackson R, Gabb BW: Cimetidine treatment of duodenal ulceration. Short-term clinical trial and maintenance study. Gastroenterology 74(2):389–392, 1978

    Google Scholar 

  20. Collen MJ, Stanczak VJ, Ciarleglio CA: Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication). Dig Dis Sci 34:233–237, 1989

    Google Scholar 

  21. Rune SJ, Hesselfeldt P, Larsen NE: Clinical and pharmacological effectiveness of cimetidine in duodenal ulcer patients. Scand J Gastroenterol 14:489–492, 1979

    Google Scholar 

  22. Hasan N, Sircus W: The factors determining success or failure of cimetidine treatment of peptic ulcer. J Clin Gastroenterol 3:225–229, 1981

    Google Scholar 

  23. Deakin M, Colin Jones DG, Williams JG: Pharmacological response to cimetidine and healing of duodenal ulceration: Effects of high-dose cimetidine and combination of cimetidine and pirenzepine. Aliment Pharmacol Ther 2:83–91, 1988

    Google Scholar 

  24. Bardhan KD: Refractory duodenal ulcer. Gut 25:722–727, 1984

    Google Scholar 

  25. Poleski MH, Martin F, Reilly RA, Kazim F, Meunier P, Williams CV: Factors affecting acute healing of duodenal ulcer. Gastroenterology 88:1541–1546, 1985

    Google Scholar 

  26. Delchier JC, Isal JP, Eriksson S, Soule JC: Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers. Gut 30:1173–1178, 1989

    Google Scholar 

  27. Kohly Y, Misaki F, Kawai K: Endoscopic follow-up observation of duodenal ulcer. Endoscopy 4:202–208, 1972

    Google Scholar 

  28. Nava G, Pippa G, Ballanti R, Papi C: Role of ulcer morphology in evaluating prognosis and therapeutic outcome in duodenal ulcer. Scand J Gastroenterol 14(suppl 54):41–43, 1979

    Google Scholar 

  29. Cortot A, Henry-Amar M, Paris JC, Pappo M: A comparison of ranitidine (150 mg×2) versus cimetidine (400 mg×2) in the treatment of acute duodenal ulcer. A French multicentre controlled therapeutic trial. Gastroenterol Clin Biol 11(2):136–141, 1987

    Google Scholar 

  30. Binder HJ, Cocco A, Crossley RJ, Finkelstein W, Font R, Friedman G, Groarke J, Hughes W, Johnson AF, McGuigan JE, Saummers R, Vlahcevic R, Wilson EC, Winship DH: Cimetidine in the treatment of duodenal ulcer. A multicentre double-blind study. Gastroenterology 74(2):380–388, 1978

    Google Scholar 

  31. Peden NR, Boyd EJS, Wormsley KG: Women and duodenal ulcer. Br Med J 282:866–871, 1981

    Google Scholar 

  32. Goodman AJ, Kerrigan DD, Johnson AG: Effect of the preoperative response to H2-receptor antagonists on the outcome of highly selective vagotomy for duodenal ulcer. Br J Surg 74:897–899, 1987

    Google Scholar 

  33. Peterson GM, Lam SK, Samloff IM, Jing J, Rotter JI: Genetic factors predict duodenal ulcer healing. Gastroenterology 88:1538–1543, 1985

    Google Scholar 

  34. Doll R, Jones AF, Pygott F: Effect of smoking on the production and maintenance of gastric and duodenal ulcers. Lancet 1:657–666, 1958

    Google Scholar 

  35. Battaglia G, Di Mario F, Piccoli A, Vianello F, Farinati F, Naccarato R: Clinical markers of slow healing and relapsing gastric ulcer. Gut 28:210–215, 1987

    Google Scholar 

  36. Gwyn Morgan A, McAdam WAF, Pacsoo C, Walker BE, Simmons AV: Cimetidine: An advance in gastric ulcer treatment? Br Med J 2:1323–1326, 1978

    Google Scholar 

  37. Gwyn Morgan A, McAdam WAF, Pacsoo C, Darnborough A: Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut 23:545–551, 1982

    Google Scholar 

  38. The Belgian Peptic Ulcer Study Group: Single blind comparative study of ranitidine and cimetidine in patients with gastric ulcer. Gut 25:999–1002, 1984

    Google Scholar 

  39. Kellow JE, Barr GD, Cowen AE, Ward M, Wood L, Piper DW: Comparison of ranitidine and cimetidine in the treatment of chronic gastric ulcer. Digestion 27:105–110, 1983

    Google Scholar 

  40. Sutton DR: Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse. Gut 23:621–624, 1982

    Google Scholar 

  41. Okada M, Yao T, Fuchigami T, Imamura K, Omae T: Factors influencing the healing rate of gastric ulcer in hospitalized subjects. Gut 25:881–885, 1984

    Google Scholar 

  42. Hjortrup A, Svendsen LB, Beck H, Hoffman J, Schroeder M: Two daily doses of sucralfate or cimetidine in the healing of gastric ulcer—a comparative randomized study. Am J Med 86(6A):113–115, 1989

    Google Scholar 

  43. Leroux P, Farley A, Archambault A, Pilon G, Gosselin D, Parê P, Lévesque D, Sherbariuk R, Thomson ABR: Effect of ranitidine on healing of peptic ulcer: a 2-month study. Am J Gastroenterol 78:227–230, 1983

    Google Scholar 

  44. Walan A, Bader JP, Classen M, Lamers CBHW, Piper DW, Kutgersson K, Eriksson S: Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 320:69–75, 1989

    Google Scholar 

  45. O'Loughlin JC, Silvoso GR, Ivey KJ: Healing of aspirinassociated peptic ulcer disease despite continued salicylate ingestion. Arch Intern Med 141:781–783, 1981

    Google Scholar 

  46. Battaglia G, Di Mario F, Vianello F, Aggio L, Cannizzaro R, De Lazzari F, Naccarato R: Alcohol consumption in the management of duodenal ulcer disease: A two year study. Ital J Gastroenterol 17:262–264, 1985

    Google Scholar 

  47. Szabo S, Hollander D: Pathways of gastrointestinal protection and repair: mechanisms of action of sucralfate. Am J Med 86(6A):23–31, 1989

    Google Scholar 

  48. Lam SK, Ong GB: Duodenal ulcer: Early and late onset. Gut 17:169–179, 1976

    Google Scholar 

  49. Lam SK, Koo J, Sircus W: Early and late onset duodenal ulcers in Chinese and Scots. Scand J Gastroenterol 18:651–681, 1983

    Google Scholar 

  50. Kang JY: Age of onset of symptoms in duodenal and gastric ulcer. Gut 31:854–857, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was performed under the auspices of the “R. Farini” Foundation for Gastrointestinal Research.

Centers participating in the study: Alba (G. Prandi, R. Bianco); Asti (C. Moro, M. Grassini); Avezzano (A. de Sanctis, A. Sedici); Belluno (F. Costan Biedo, P. Olivieri); bussolengo (S. Adamo, G. Sartori); Cagliari (P. Loriga, C. Caschili); Castelfranco V. to (S. Bertazzo, G. Pesce); Castrovillari (S. Leone, G. Mollica); Conegliano V. to (G. Lollo, P. Lunardi); Cosenza (A. Belmonte, G. Manno); Cuneo (G. Ferro, A. Manca); Fano (M. Cuzzupoli, A. Olivieri); Fiesole (P. Ciani, L. Manneschi); Gorizia (E. Benedetti, S. Fayenz); Lanciano (S. Di Matteo, F. Cifani); Malo (C.F. Azzini, A. Pilotto); Monza (S. Magni, A. Lomazzi); Melito P.S. (G. Dattola); Napoli (B. De Luca, D. Di Cesare); Negrar (A. Geccherle, C. Manfrini); Novara (M. Del Piano, F. Montino); Orbassano (G. Emanueli, C. Calcamuggi); Oristano (A. Tuveri, M. Sau); Padova (R. Naccarato, F. Di Mario); Palermo (G. Barbagallo-Sangiorgi, S. Vigneri); Polistena (G. Gerace); Popoli (A. Pomidori, R. Lattanzio); Prato (A. Candidi-Tomasi, M. Lami); Reggio Calabria (P. Califano, C. Campolo); Roma (L. Capurso, M. Koch); Rovereto (A. Bernardi, M.C. Paler); S. Vito al Tagliamento (G. Tasca, A. Pighin); Scilla (G. Naim); Terni (A. Della Spoletina, F. Bellavigna); Torino (G. Babando, L. Lombardo); Venezia (M. Pasquino, M.E. Benvenuti); Vercelli (W. Giorgelli, G. Ardizzone).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Battaglia, G., Di Mario, F., Dotto, P. et al. Markers of slow-healing peptic ulcer in the elderly. Digest Dis Sci 38, 1414–1421 (1993). https://doi.org/10.1007/BF01308597

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01308597

Key words

Navigation